RT Journal Article
SR Electronic
T1 756 First-in-human, open-label, multicenter, phase 1 clinical study to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of anti Siglec-15 PYX-106 in subjects with advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A852
OP A852
DO 10.1136/jitc-2023-SITC2023.0756
VO 11
IS Suppl 1
A1 Spira, Alexander I
A1 Gordon, Michael S
A1 Henry, Jason
A1 Patel, Sandip P
A1 Sehgal, Kartik
A1 Sen, Shiraj
A1 Sweis, Randy
A1 Crochiere, Marsha
A1 He, Shui
A1 Smyrnios, Sondra
A1 Unadkat, Dipali
A1 Zhang, Bin
A1 Tolcher, Anthony W
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A852.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.